The severity of harm score database: an evidence-based foundation for laboratory test risk analysis
Authors:
- Hikmet Can ÇubukçuHÇHikmet Can Çubukçu
- Oswald SonntagOSOswald Sonntag
- Nathan LordeNLNathan Lorde
- Charles R. LefèvreCLCharles R. Lefèvre
- Chiara CosmaCCChiara Cosma
- Annelien Van DalemADAnnelien Van Dalem
- Panagiotis N. KanellopoulosPKPanagiotis N. Kanellopoulos
- Marija KocijancicMKMarija Kocijancic
- Guilaine BoursierGBGuilaine Boursier
- Pika Meško BrguljanPBPika Meško Brguljan
- Neda MilinkovicNMNeda Milinkovic
- Marith van Schrojenstein LantmanMLMarith van Schrojenstein Lantman
- 29 July 2026
- journal article
- Published by Walter de Gruyter GmbH in Clinical Chemistry and Laboratory Medicine (CCLM)
Abstract
Background: Patient risk management has become central to clinical laboratory quality standards, including the Clinical and Laboratory Standards Institute (CLSI) EP23 2nd edition (CLSI EP23-ED2), International Organization for Standardization (ISO) 15189:2022, ISO 22367:2026, and ISO 14971:2019. A key component of risk analysis is estimating the severity of harm (SoH) that may result from erroneous laboratory results. We present here the Severity of Harm Evidence Database, a structured, multi-study resource that integrates survey-based SoH assessments from the published independent studies. The database provides ordinal distributions and pooled SoH for 196 unique laboratory tests. Methods: A canonical five-level scale (negligible, minor, serious, critical, catastrophic) was adopted, aligned with ISO 14971:2019. For the 19 tests common to both studies, direct count pooling was performed by summing category-level respondent counts. Wilson score confidence intervals were calculated for all proportions. The database is organized into nine relational sheets and is accompanied by an interactive web application. Results: Out of the 196 tests covered, 19 have pooled estimates from both studies (total n=781 respondents). Pooled analysis confirms that cardiac biomarkers, blood gases, coagulation parameters, electrolytes (potassium, sodium), and therapeutic drug concentrations (digoxin, lithium) consistently receive the highest severity ratings, while certain endocrine markers receive lower scores. Conclusions: The SoH evidence database offers the first publicly available, structured repository of SoH assessments for clinical laboratory tests. It supports compliance with risk management requirements, informs risk-based strategies per CLSI EP23-ED2, and provides an evidence-based foundation for laboratory risk analysis.Keywords
This publication has 8 references indexed in Scilit:
- Patient risk management in laboratory medicine: an international survey to assess the severity of harm associated with erroneous reported resultsClinical Chemistry and Laboratory Medicine (CCLM), 2025
- EN ISO 15189 revision: EFLM Committee Accreditation and ISO/CEN standards (C: A/ISO) analysis and general remarks on the changesClinical Chemistry and Laboratory Medicine (CCLM), 2025
- Measuring the impact: Severity of harm from laboratory errors in 195 testsAmerican Journal of Clinical Pathology, 2024
- QC Constellation: a cutting-edge solution for risk and patient-based quality control in clinical laboratoriesClinical Chemistry and Laboratory Medicine (CCLM), 2024
- Falsely Elevated Digoxin Levels in Patients on EnzalutamideCirculation: Heart Failure, 2020
- The Value of In Vitro Diagnostic Testing in Medical Practice: A Status ReportPLOS ONE, 2016
- Process and risk analysis to reduce errors in clinical laboratoriesClinical Chemistry and Laboratory Medicine (CCLM), 2007
- Approximate is Better than “Exact” for Interval Estimation of Binomial ProportionsThe American Statistician, 1998